16/12/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

16/12/2024

Dec 16, 2024, 19:31 | Insight
RADIOSA Trial: SBRT vs SBRT and ADT for oligorecurrent Prostate Cancer - UroToday.com
UroToday.com shared a post on X: “RADIOSA Trial: SBRT vs SBRT and ADT for oligorecurrent…
Dec 16, 2024, 19:28 | Insight
Akhil Santhosh: The key differences between “KEYNOTE 522” and “CAMRELIEF”
Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post…
Dec 16, 2024, 19:16 | Blog
Ameish Govindarajan joins Cleveland Clinic MD for Hematology Oncology Fellowship
Ameish Govindarajan, Frances Young Tang Research Fellow at Memorial Sloan Kettering Cancer Center, shared a…
Dec 16, 2024, 19:13 | Blog
Suresh S. Ramalingam on insurance coverage challenges for Keytruda in NSCLC Patients
Suresh S. Ramalingam, Executive Director of Winship Cancer Institute of Emory University, shared a post…
Dec 16, 2024, 19:10 | Insight
Neoadjuvant durvalumab improves survival in early TNBC independent of pathological complete response
Akhil Santhosh, Medical Oncologist at Dr BR Ambedkar Institute Rotary Cancer Hospital, shared a post on…
Dec 16, 2024, 19:07 | Insight
Julie Hallet: Guidance on biomarkers gene therapy for NETs
Julie Hallet, Assistant Professor of Surgery at the University of Toronto, shared a post on…
Dec 16, 2024, 19:04 | Blog
Elshad Hasanov: Vision for the future - a colorful, beautiful, and healthy brain - free of metastasis
Elshad Hasanov, Physician-Scientist at The Ohio State University Comprehensive Cancer Center, shared a post on X: "Blessed…
Dec 16, 2024, 19:00 | Blog
Xiuning Le: Successful EGFR Resisters Research Summit
Xiuning Le shared a post on X: "Congrats! EGFR Resisters for the successful EGFR Resisters…
Dec 16, 2024, 18:57 | Insight
Next generation sequencing-based MSI scoring predict benefit in dMMR tumors treated with nivolumab
María Natalia Gandur Quiroga shared a post on X: "NGS-Based MSI Scoring Predicts Nivolumab Benefit…
Dec 16, 2024, 18:53 | Blog
City Cancer Challenge - A career-defining challenge proving that nothing is impossible
City Cancer Challenge shared on LinkedIn: "Sometimes, opportunity knocks. For Dr. Maka Maglakelidze, it didn’t…
All: 99 Posts: 11 - 20
Special Coverage